Balloon catheter market seen reaching $5.25 billion by 2030

The global balloon catheters market is forecast to grow from $4.11 billion in 2025 to $5.25 billion by 2030, according to The Business Research Company. Growth is being driven by minimally invasive procedures, outpatient care, and new catheter technologies, with North America leading and Asia-Pacific growing fastest.

Why it matters: - Balloon catheters are central to minimally invasive cardiovascular procedures, especially angioplasty, where they help open narrowed blood vessels and reduce the need for open surgery. - The market’s projected growth points to rising demand for less invasive treatments, more outpatient care, and continued investment in cardiovascular devices.

What happened: - The Business Research Company released its Balloon Catheters Global Market Report 2026, covering market size, trends, and forecasts for 2026-2035. - The report projects the balloon catheters market will grow from $4.11 billion in 2025 to $4.32 billion in 2026. - The report forecasts the market will reach $5.25 billion by 2030, expanding at a 5.0% CAGR. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Historical growth has been supported by rising cardiovascular disease rates, more angioplasty procedures, expanding catheterization labs, advanced interventional cardiology technologies, and stronger clinical expertise in endovascular treatment. - Forecast growth is tied to innovations in balloon catheter coatings, greater use of outpatient interventional procedures, broader acceptance of minimally invasive treatments, increased use of precision-guided devices, and higher R&D spending in cardiovascular devices. - The report identifies drug-eluting balloon catheters, high-pressure balloons, scoring balloons, and treatments for peripheral artery disease as key trends. - Balloon catheters are thin, flexible tubes with an inflatable balloon near the tip. - The devices are used to treat narrowed or blocked blood vessels by inflating the balloon to restore blood flow. - The design allows controlled intervention with less trauma than traditional open surgery. - The report links the rise in minimally invasive surgery to balloon catheter demand, citing smaller incisions, shorter recovery times, and lower complication risk as core benefits. - Intuitive Surgical said in January 2024 that it placed 415 da Vinci surgical systems in Q4 2023, up 12% from 2022, underscoring broader adoption of minimally invasive robotic surgery. - The report says technological advances and the shift to outpatient care are also supporting demand for drug-eluting balloons and precision-guided systems. - The report’s regional scope also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Between the lines: - The forecast suggests balloon catheters are benefiting from the same care shift reshaping much of cardiovascular medicine: less invasive procedures, faster throughput, and greater procedural precision. - North America's lead reflects mature healthcare infrastructure and high procedure volume, while Asia-Pacific's growth outlook points to expanding access and capacity. - The emphasis on coatings, precision guidance, and drug-eluting technology suggests competition is shifting toward product performance and patient safety.

What's next: - The market is likely to keep expanding as providers adopt more outpatient interventional procedures and minimally invasive cardiovascular treatments. - Further adoption of drug-eluting and precision-guided balloon catheters could shape product development and procurement priorities. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables. - More information is available in the full report and the free sample.